Journal of the Peripheral Nervous System

Article	Citations
	69
	31
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	30
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	29
PNS Abstracts 2023	24
Identifying Predictors of Idiopathic Small‐Fiber Neuropathy in Adolescent Patients With Chronic Pain	21
	21
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	21
Prospective Evaluation of Machine‐Assisted Electrophysiologic and Online Clinical Diagnostic Support Tools in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	21
Abstracts	21
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	20
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	20
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	18
Issue Information	18
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	16
Ofatumumab for treating autoimmune nodopathy	15
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	15
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	14
Broadening the Clinical Spectrum of Axonal Hereditary Neuropathies: A Comparative Case Study on DNAJB2‐ and HINT1‐	14
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	14
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	13
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	13
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	13
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	13
Issue Information	13

Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	13
Behavioral Thermoceptive Responses and Morphologic Correlates in Mouse Models of CMT1A , HNPP , an	12
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	12
Issue Information	12
Issue Information	11
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	11
A Novel Case of Nerve Biopsy Proven Wild Type Transthyretin (TTR) Amyloidosis	11
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	11
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	11
Cranial Nerve Involvement With Diplopia as Presenting Feature of CMT1H Caused by Recurring FBLN5 Varia	11
Novel Dominant Splicing Variant in MPZ Associated With Unusual Charcot–Marie–Tooth Disease	11
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	11
Rethinking Neuropathy in TTC19 Mutations: The Need for Broader Differential Diagnosis	10
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	10
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	10
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	9
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	9
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	9
Frequent De Novo Mutations in Korean Patients With Charcot–Marie–Tooth Disease	9
Unveiling a Regional Variant of Demyelinating Guillain–Barré Syndrome: Nerve Conduction Study Evidence in Bifacial Weakness With Paresthesias	9
Peter James Dyck: In Memoriam	9
Issue Information	8
Issue Information	8
	8
	8
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
Issue Information	7
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	7
Molecular Characterization of Oxaliplatin‐Induced Peripheral Neurotoxicity: The Complex Spectrum of Painful Manifestations	6
Correction to “Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System”	6
	6
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
The autoimmune vulnerability of the node of Ranvier	6
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	6
Measurement of Red Blood Cell Sorbitol Dehydrogenase Activity for Fast Screening of SORD ‐Related Neuropathies	6
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	6
	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
	6
Overall Diagnostic Performance of Multiple Versus Single Physical Examination Tests for the Prediction of Future Diabetic Neuropathy Risk	6
Issue Information	6
ABSTRACT	6
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
Impact of High‐Dose Tafamidis on Hereditary ATTR ( ATTRv ) Amyloidosis With Central Nervous System	5
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	5
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	5
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	5
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5

Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	5
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	5
Nonsystemic Vasculitic Neuropathy—A Brazilian Case Series	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	5
Issue Information	5
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	5
Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	5
SOX5 Overexpression in Schwann Cell Combined With Chitosan‐Based Conduit Promotes Peripheral Nerve Regeneration	4
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	4
Rasch‐Built Overall Disability Scale for IgM‐Associated Polyneuropathy With and Without Anti‐MAG Antibodies: IgM‐RODS	4
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	4
A Case of Retinopathy–Sensory Neuropathy Syndrome With a Novel Compound Heterozygous FLVCR1 Varian	4
A New Simple SCreening Tool for Painful Diabetic Neuropathy ( ACT ) in Ecuador	4
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	4
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	4
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	4
Anxiety and depression in small fiber neuropathy	4
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	4
Pathological Features of Vasculitic Neuropathy and the Role of Nerve Biopsy	4
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	4
Issue Information	4
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	4
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	4
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	4
Elucidating Causal Associations Between Immune Cells, Circulating Inflammatory Proteins, and Chronic Inflammatory Demyelinating Polyneuropathy: A Two‐Sample Two‐Step Mendelian Randomization Study	4
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis	3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury	3
Longitudinal Assessment of Quality of Life and Functionality by CAP ‐ PRI in Patients With Active	3
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal	3
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus	3
	3
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome	3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years	3
Blood 1‐Deoxysphingolipid Levels Are Associated With Epidermal Denervation in Small Fiber Neuropathy	3
Etiologic Diagnosis of Neuropathies Based on First‐Line Screening of TTR Gene Mutations	3
Issue Information	3
Issue Information	3
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies	3
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves	3
Validation and Reliability of the Thai Pediatric Charcot–Marie–Tooth Quality of Life Outcome Measure	3
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children	3
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes	2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit	2
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders	2
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria	2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy	2
Cytokine Dynamics in Bortezomib‐Induced Peripheral Neuropathy: Challenges in Translating Preclinical Findings to Humans	2
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement	2
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy	2
Leptospirosis‐induced acute acquired inflammatory neuropathy	2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor	2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?	2
Abstract	2
Correction to “The Correlation Between Functional and Morphometric Small Fiber Assessment in Mixed Etiology Polyneuropathy”	2
A Next‐Generation ELISA for the Detection of Anti‐(Para)Nodal Antibodies in Autoimmune Nodopathy and COVID	2
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa	2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN1	2
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome	2
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation	2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients	2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla	2
Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration	2
	2
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System	2
Epidemiology, Presentation, Management and Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy in Birmingham, UK : The Impact of Ethnicity	2
	2
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report	2
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?	1
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity	1
Serum neurofilament light chain measurements following nerve trauma	1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome	1
	1
Long‐Term Functional Outcomes in Immunoglobulin‐Treated Multifocal Motor Neuropathy Evaluated Through the MMN ‐Rasch‐Built Overall Disability Scale	1
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)	1
	1
Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy	1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy	1
Laura Feltri: In memoriam	1

Intrathecal Antibody Synthesis in Autoimmune Nodopathy	1
CIDP With and Without Monoclonal Gammopathy of Undetermined Significance ( MGUS ): Comparison of Clinical Phenotype, D	1
Issue Information	1
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome	1
Motor Neuropathy in a Patient With Mitochondrial Disease and a Novel TTC19 Variant: An Underrecognized Phenotypic Feature	1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A1	1
Sural nerve biopsy utility by masked assessment of individual histologic preparations	1
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report	1
Polyneuropathy in Kidney Transplant Recipients: Accuracy of a New Clinical Diagnostic Scoring System	1
Issue Information	1
Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing	1
Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape	1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy	1
Issue Information	1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges	1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy	1
Motor Neuronopathy With Widespread Fasciculations in MCM3AP ‐Related Disorder: Clinical and Muscle MRI	1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents	1
Issue Information	1
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course	1
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Hereditary Transthyretin Amyloidosis Polyneuropathy	1
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review	1
The Easy Handgrip Test as a Tool for Assessing Motor Fatigability in Children With Charcot‐Marie‐Tooth Disease Type 1A	1
Issue Information	1
Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases	1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy	1
Human Cytomegalovirus Associated Neuropathies: A Comprehensive Review From Pathophysiology to Clinical and Therapeutic Considerations	1
Identification of cellular and noncellular components of mature intact human peripheral nerve	1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response	1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study	1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies	1
	1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”	1
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A	1
Pseudodominant Inheritance of Biallelic RFC1 Expansions—Revisiting the 3p22‐p24	1
ITPR1 Deletion in a Patient With Sensory Ataxic Neuropathy and Sjögren Syndrome	1
Issue Information	1
Abstract	1
Designing and Implementing a Web‐Based Platform for Accurate and Reliable Clinical Outcome Measures and Global Certification for Evaluating Charcot–Marie–Tooth disease	1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome	1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset	1
	1